We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CNTA market cap is 2.37B. The company's latest EPS is USD and P/E is N/A.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |||
Total Revenue | 0 | 0 | 6.85M | 0 | 0 |
Operating Income | -47.02M | -44.76M | -30.63M | -36.09M | -43.98M |
Net Income | -24.89M | -38.65M | -36.84M | -38.05M | -43.82M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 6.85M |
Operating Income | -374.08M | -212.26M | -171.28M |
Net Income | -381.07M | -216.21M | -151.09M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |||
Total Assets | 392.92M | 377.36M | 360.25M | 328.17M | 398.85M |
Total Liabilities | 116.32M | 117.97M | 124M | 113.01M | 111.88M |
Total Equity | 276.61M | 259.39M | 236.24M | 215.16M | 286.97M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 629.64M | 444.31M | 360.25M |
Total Liabilities | 138.08M | 108.14M | 124M |
Total Equity | 491.55M | 336.17M | 236.24M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |||
Operating | -91.9M | -129.29M | -160.34M | -37.29M | -77.87M |
Investing | -157.44M | -108.73M | -127M | 16.76M | -38.7M |
Financing | 12k | 14.76M | 21.12M | 10.49M | 115.81M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Operating | -135.11M | -200.55M | -160.34M |
Investing | 63.26M | -931k | -127M |
Financing | 660.15M | 457k | 21.12M |
Market Cap | 2.37B |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 131.85M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 1.59 (8.9%) |
Company Name | Centessa Pharmaceuticals PLC |
Address |
3rd floor cheshire WA14 2DT |
Website | https://www.centessa.com |
Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions